QUOTIENT SCIENCES
Live / Applied — Response to non-final action entered (as of 01 Dec 2025)
What this means for you
Not registered yet, but its 17 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79417429
- Mark type
- Stylized text
- Filed
- 17 Sept 2024
- Attorney of record
- Jonathan Soifer
Goods and services
- Class 039 — Transportation and storage services: Contract packaging services in the nature of packaging and labelling of pharmaceutical and biopharmaceuticals for distribution on behalf of third parties; contract packaging and labelling for other in the nature of merchandise packaging and labelling for others; storage services, namely, warehousing and temperature controlled storage of goods for others; transportation logistics services, namely, arranging transportation of goods for others; packaging articles to the order and specification of others; contract packaging of pharmaceutical, biopharmaceutical and clinical supplies and materials for others
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals and biopharmaceuticals; custom manufacture of pharmaceuticals and biopharmaceuticals for clinical trial purposes; manufacturing services for clinical trials, namely manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; Providing information in the field of custom manufacturing and testing of pharmaceutical and biopharmaceutical products.
- Class 042 — Scientific and technological services: Clinical research in the field of pharmacology and medical research; medical and scientific research, namely, conducting clinical trials for others; medical research, namely, conducting clinical trials for others in the field of pharmaceutical and biopharmaceutical products; pharmaceutical and biopharmaceutical research services; pharmaceutical and biopharmaceutical testing services; research relating to science namely, scientific research; Scientific research in the nature of basic and clinical research in the fields of pharmacology, pharmaceuticals and biopharmaceuticals; Evaluation and analysis of the efficacy and dosages of pharmaceutical and biopharmaceutical products of others and dosages in the nature of analysis and evaluation of pharmaceutical and biopharmaceutical products and dosages of others to determine conformity with certification standards and to assure compliance with industry standards; pharmaceutical and biopharmaceutical product evaluation; providing medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals and clinical trials; biological research; research and development of vaccines and medicines; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical products development; pharmaceutical and biopharmaceutical formulation design and development services, namely development of pharmaceutical and biopharmaceutical preparations and medicines; pre-formulation screening services, namely conducting early evaluations in the field of new pharmaceutical and testing, inspection and research of pharmaceuticals; scientific research in the nature of conducting clinical trials for others for the purpose of optimisation of pharmaceutical and biopharmaceutical formulations and dosage through clinical testing; development of pharmaceutical and biopharmaceutical preparations and medicines, research and development of vaccines and medicines, product research and development, product development for others; Research relating to medicine, namely, medical research in the field of pharmacology; Medical research in the nature of basic and clinical research in the field of pharmacology; consultancy relating to testing, inspection and research of pharmaceuticals and biopharmaceuticals; consultancy in the field of pharmacology; clinical pharmacology, namely technical research, testing and consulting in the field of pharmaceutical and biopharmaceutical studies; laboratory research services relating to pharmaceuticals.
Owner
Prosecution history
- 26 Feb 2026 — ASSIGNED TO EXAMINER
- 01 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Jul 2025 — REFUSAL PROCESSED BY IB
- 23 Jun 2025 — ASSIGNED TO LIE
- 14 Jun 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 14 Jun 2025 — REFUSAL PROCESSED BY MPU
- 15 Apr 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 14 Apr 2025 — NON-FINAL ACTION WRITTEN
- 17 Mar 2025 — ASSIGNED TO EXAMINER
- 14 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 14 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Mar 2025 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 20 Feb 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB